Spurious electrolyte disorders refer to an artifactually elevated or decreased serum electrolyte values that do not correspond to their actual systemic levels. When a clinician is confronted with a case of electrolyte disturbance, the first question should be whether it is an artifact. Spurious electrolyte disorders (pseudohyponatremia, pseudohypernatremia, pseudohypokalemia, pseudohyperkalemia, pseudohypomagnesemia, pseudohypophosphatemia, pseudohyperphosphatemia, pseudohypocalcemia and pseudohypercalcemia) are not infrequently observed in clinical practice. The recognition that an electrolyte disturbance may be an artifact may prevent inappropriate therapeutic interventions that could potentially have unfavorable outcomes. Clinicians must be alert to the possibility of spurious laboratory abnormalities when faced with conflicting laboratory values or measurements that are discordant with the clinical presentation. Moreover, in the presence of conditions that predispose to spurious electrolyte disorders, the normal measured electrolyte levels should raise the suspicion that true electrolyte disorders may be present.

Keywords:
Ion-selective electrodes, Pseudohyperkalemia, Pseudohyperphosphatemia, Pseudohypocalcemia, Pseudohyponatremia, Pseudohypomagnesemia
1.
Liamis G, Rodenburg EM, Hofman A, Zietse R, Stricker BH, Hoorn EJ: Electrolyte disorders in community subjects: prevalence and risk factors. Am J Med 2013;126:256-263.
2.
Elisaf MS, Milionis HJ, Siamopoulos KC: Electrolyte abnormalities in elderly patients admitted to a general medical ward. Geriatr Nephrol Urol 1997;7:73-79.
3.
Milionis HJ, Liamis GL, Elisaf MS: The hyponatremic patient: a systematic approach to laboratory diagnosis. CMAJ 2002;166:1056-1062.
4.
Weisberg LS: Pseudohyponatremia: a reappraisal. Am J Med 1989;86:315-318.
5.
Turchin A, Seifter JL, Seely EW: Clinical problem-solving. Mind the gap. N Engl J Med 2003;349:1465-1469.
6.
Nguyen MK, Ornekian V, Butch AW, Kurtz I: A new method for determining plasma water content: application in pseudohyponatremia. Am J Physiol Renal Physiol 2007;292:F1652-F1656.
7.
Maas AH, Siggaard-Andersen O, Weisberg HF, Zijlstra WG: Ion-selective electrodes for sodium and potassium: a new problem of what is measured and what should be reported. Clin Chem 1985;31:482-485.
8.
Garibaldi BT, Cameron SJ, Choi M: Pseudohyponatremia in a patient with HIV and hepatitis C coinfection. J Gen Intern Med 2008;23:202-205.
9.
Steinberger BA, Ford SM, Coleman TA: Intravenous immunoglobulin therapy results in post-infusional hyperproteinemia, increased serum viscosity, and pseudohyponatremia. Am J Hematol 2003;73:97-100.
10.
Nanji AA, Blank DW: Pseudohyponatremia and hyperviscosity. J Clin Pathol 1983;36:834-835.
11.
Steinberger B, Coleman TA: Multiple complications of IVIG therapy in a patient with Guillain-Barre syndrome. Am J Hematol 2001;67:59.
12.
Story DA, Morimatsu H, Egi M, Bellomo R: The effect of albumin concentration on plasma sodium and chloride measurements in critically ill patients. Anesth Analg 2007;104:893-897.
13.
Dimeski G, Barnett RJ: Effects of total plasma protein concentration on plasma sodium, potassium and chloride measurements by an indirect ion selective electrode measuring system. Crit Care Resusc 2005;7:12-15.
14.
Lang T, Prinsloo P, Broughton AF, Lawson N, Marenah CB: Effect of low protein concentration on serum sodium measurement: pseudohypernatraemia and pseudonormonatraemia! Ann Clin Biochem 2002;39:66-67.
15.
Dimeski G, Morgan TJ, Presneill JJ, Venkatesh B: Disagreement between ion selective electrode direct and indirect sodium measurements: estimation of the problem in a tertiary referral hospital. J Crit Care 2012;27:326. e9-e16.
16.
Naparstek Y, Gutman A: Case report: spurious hypokalemia in myeloproliferative disorders. Am J Med Sci 1984;288:175-177.
17.
Adams PC, Woodhouse KW, Adela M, Parnham A: Exaggerated hypokalaemia in acute myeloid leukaemia. BMJ 1981;282:1034-1035.
18.
Kone BC: Hypokalemia; in DuBose TD, Hamm LL: Acid-Base and Electrolyte Disorders: A Companion to Brenner & Rector's The Kidney. Philadelphia, Saunders, 2002, pp 384.
19.
Masters PW, Lawson N, Marenah CB, Maile LJ: High ambient temperature: a spurious cause of hypokalaemia. BMJ 1996;312:1652-1653.
20.
Sodi R, Davison AS, Holmes E, Hine TJ, Roberts NB: The phenomenon of seasonal pseudohypokalemia: effects of ambient temperature, plasma glucose and role for sodium-potassium-exchanging-ATPase. Clin Biochem 2009;42:813-818.
21.
Dharmarajan TS, Nguyen T, Russell RO: Life-threatening, preventable hyperkalemia in a nursing home resident: case report and literature review. J Am Med Dir Assoc 2005;6:400-405.
22.
Smellie WS: Spurious hyperkalaemia. BMJ 2007;334:693-695.
23.
Mandal AK: Hypokalemia and hyperkalemia. Med Clin North Am 1997;81:611-639.
24.
Graber M, Subramani K, Corish D, Schwab A: Thrombocytosis elevates serum potassium. Am J Kidney Dis 1988;12:116-120.
25.
Colussi G, Cipriani D: Pseudohyperkalemia in extreme leukocytosis. Am J Nephrol 1995;15:450-452.
26.
Abraham B, Fakhar I, Tikaria A, Hocutt L, Marshall J, Swaminathan S, et al: Reverse pseudohyperkalemia in a leukemic patient. Clin Chem 2008;54:449-451.
27.
Meng QH, Krahn J: Reverse pseudohyperkalemia in heparin plasma samples from a patient with chronic lymphocytic leukemia. Clin Biochem 2011;44:728-730.
28.
Wulkan RW, Michiels JJ: Pseudohyperkalaemia in thrombocythaemia. J Clin Chem Clin Biochem 1990;28:489-491.
29.
Ong YL, Deore R, El-Agnaf M: Pseudohyperkalaemia is a common finding in myeloproliferative disorders that may lead to inappropriate management of patients. Int J Lab Hematol 2010;32:e151-e157.
30.
Ahmed R, Isaac AM: Postsplenectomy thrombocytosis and pseudohyperkalemia in trauma: a case report and review of literature. J Trauma 2009;67:E17-E19.
31.
Ralston SH, Lough M, Sturrock RD: Rheumatoid arthritis: an unrecognised cause of pseudohyperkalaemia. BMJ 1988;297:523-524.
32.
Don BR, Sebastian A, Cheitlin M, Christiansen M, Schambelan M: Pseudohyperkalemia caused by fist clenching during phlebotomy. N Engl J Med 1990;322:1290-1292.
33.
Ismail A, Shingler W, Seneviratne J, Burrows G: In vitro and in vivo haemolysis and potassium measurement. BMJ 2005;330:949.
34.
Meenaghan M, Follett GF, Brophy PJ: Temperature sensitivity of potassium flux into red blood cells in the familial pseudohyperkalaemia syndrome. Biochim Biophys Acta 1985;821:72-78.
35.
Alani FS, Dyer T, Hindle E, Newsome DA, Ormerod LP, Mahoney MP: Pseudohyperkalaemia associated with hereditary spherocytosis in four members of a family. Postgrad Med J 1994;70:749-751.
36.
Garwicz D, Karlman M: Early recognition of reverse pseudohyperkalemia in heparin plasma samples during leukemic hyperleukocytosis can prevent iatrogenic hypokalemia. Clin Biochem 2012;45:1700-1702.
37.
Singh PJ, Zawada ET, Santella RN: A case of ‘reverse' pseudohyperkalemia. Miner Electrolyte Metab 1997;23:58-61.
38.
Dickinson H, Webb NJ, Chaloner C, Wynn RF, Bonney DK: Pseudohyperkalaemia associated with leukaemic cell lysis during pneumatic tube transport of blood samples. Pediatr Nephrol 2012;27:1029-1031.
39.
Rifkin SI: Pseudohyperkalemia in patients with chronic lymphocytic leukemia. Int J Nephrol 2011;2011:759749.
40.
Ruddy KJ, Wu D, Brown JR: Pseudohyperkalemia in chronic lymphocytic leukemia. J Clin Oncol 2008;26:2781-2782.
41.
Boden SD, Kaplan FS: Calcium homeostasis. Orthop Clin North Am 1990;21:31-42.
42.
Dickerson RN, Alexander KH, Minard G, Croce MA, Brown RO: Accuracy of methods to estimate ionized and ‘corrected' serum calcium concentrations in critically ill multiple trauma patients receiving specialized nutrition support. J Parenter Enteral Nutr 2004;28:133-141.
43.
Byrnes MC, Huynh K, Helmer SD, Stevens C, Dort JM, Smith RS: A comparison of corrected serum calcium levels to ionized calcium levels among critically ill surgical patients. Am J Surg 2005;189:310-314.
44.
Williams SF, Meek SE, Moraghan TJ: Spurious hypocalcemia after gadodiamide administration. Mayo Clin Proc 2005;80:1655-1657.
45.
Moore CD, Newman RC, Caridi JG: Spurious hypocalcemia after gadodiamide-enhanced magnetic resonance imaging: a case report and review of the literature. Rev Urol 2006;8:165-168.
46.
Prince MR, Erel HE, Lent RW, Blumenfeld J, Kent KC, Bush HL, et al: Gadodiamide administration causes spurious hypocalcemia. Radiology 2003;227:639-646.
47.
Kang HP, Scott MG, Joe BN, Narra V, Heiken J, Parvin CA: Model for predicting the impact of gadolinium on plasma calcium measured by the o-cresolphthalein method. Clin Chem 2004;50:741-746.
48.
Jacobs TP, Bilezikian JP: Clinical review: rare causes of hypercalcemia. J Clin Endocrinol Metab 2005;90:6316-6322.
49.
Ladenson JH, Lewis JW, McDonald JM, Slatopolsky E, Boyd JC: Relationship of free and total calcium in hypercalcemic conditions. J Clin Endocrinol Metab 1979;48:393-397.
50.
Howard MR, Ashwell S, Bond LR, Holbrook I: Artefactual serum hyperkalaemia and hypercalcaemia in essential thrombocythaemia. J Clin Pathol 2000;53:105-109.
51.
Side L, Fahie-Wilson MN, Mills MJ: Hypercalcaemia due to calcium binding IgM paraprotein in Waldenstrom's macroglobulinaemia. J Clin Pathol 1995;48:961-962.
52.
Jaffe JP, Mosher DF: Calcium binding by a myeloma protein. Am J Med 1979;67:343-346.
53.
Annesley TM, Burritt MF, Kyle RA: Artifactual hypercalcemia in multiple myeloma. Mayo Clin Proc 1982;57:572-575.
54.
Merlini G, Fitzpatrick LA, Siris ES, Bilezikian JP, Birken S, Beychok S, et al: A human myeloma immunoglobulin G binding four moles of calcium associated with asymptomatic hypercalcemia. J Clin Immunol 1984;4:185-196.
55.
Donhowe JM, Freier EF, Wong ET, Steffes MW: Factitious hypophosphatemia related to mannitol therapy. Clin Chem 1981;27:1765-1769.
56.
Eisenbrey AB, Mathew R, Kiechle FL: Mannitol interference in an automated serum phosphate assay. Clin Chem 1987;33:2308-2309.
57.
Polderman KH, Bloemers FW, Peerdeman SM, Girbes AR: Hypomagnesemia and hypophosphatemia at admission in patients with severe head injury. Crit Care Med 2000;28:2022-2025.
58.
Larner AJ: Pseudohyperphosphatemia. Clin Biochem 1995;28:391-393.
59.
Barutcuoglu B, Parildar Z, Mutaf I, Habif S, Bayindir O: Spuriously elevated inorganic phosphate level in a multiple myeloma patient. Clin Lab Haematol 2003;25:271-274.
60.
Jamil MG, Abdel-Raheem MM, Potti A, Levitt R: Pseudohyperphosphatemia associated with Waldenstrom's macroglobulinemia. Am J Hematol 2000;65:329.
61.
Randall AG, Garcia-Webb P, Beilby JP: Interference by haemolysis, icterus and lipaemia in assays on the Beckman Synchron CX5 and methods for correction. Ann Clin Biochem 1990;27:345-352.
62.
Adler SG, Laidlaw SA, Lubran MM, Kopple JD: Hyperglobulinemia may spuriously elevate measured serum inorganic phosphate levels. Am J Kidney Dis 1988;11:260-263.
63.
Izzedine H, Camous L, Bourry E, Azar N, Leblond V, Deray G: Make your diagnosis. Multiple myeloma-associated with spurious hyperphosphatemia. Kidney Int 2007;72:1035-1036.
64.
Bailey HL, Chan EM: Liposomal amphotericin B interferes with the phosphorus assay on the Synchron LX 20 analyzer. Clin Chem 2007;53:795-796.
65.
Lane JW, Rehak NN, Hortin GL, Zaoutis T, Krause PR, Walsh TJ: Pseudohyperphosphatemia associated with high-dose liposomal amphotericin B therapy. Clin Chim Acta 2008;387:145-149.
66.
Schiller B, Virk B, Blair M, Wong A, Moran J: Spurious hyperphosphatemia in patients on hemodialysis with catheters. Am J Kidney Dis 2008;52:617-620.
67.
Kroll MH, Elin RJ: Relationships between magnesium and protein concentrations in serum. Clin Chem 1985;31:244-246.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.